One such panel is the Ion Ampliseq RNA fusion lung cancer panel offered by ThermoFisher Scientific, Waltham, USA, which targets 70 known fusion transcripts of ALK, RET, ROS1, and NTRK. This evidence concerns the gene ALK and lung carcinoma.